PFM Health Sciences’s Abbott ABT Stock Holding History

PFM Health Sciences’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.46M	Sell	82,230 -58,202	-41%	-$5.31M	0.64%	54
2026 Q1	$14.4M	Buy	+140,432	New	+$15.9M	1.31%	23
2020 Q1	–	Sell	-322,713	Closed	-$28M	–	62
2019 Q4	$28M	Buy	+322,713	New	+$27M	1.34%	29
2019 Q1	–	Sell	-1,144,699	Closed	-$82.8M	–	91
2018 Q4	$82.8M	Sell	1,144,699 -82,361	-7%	-$5.79M	2.2%	11
2018 Q3	$90M	Sell	1,227,060 -110,228	-8%	-$7.24M	1.32%	24
2018 Q2	$81.6M	Sell	1,337,288 -419,508	-24%	-$25.4M	1.28%	22
2018 Q1	$105M	Buy	1,756,796 +24,254	+1%	+$1.46M	2.14%	10
2017 Q4	$98.9M	Sell	1,732,542 -68,426	-4%	-$3.79M	2.35%	6
2017 Q3	$96.1M	Buy	1,800,968 +698,187	+63%	+$35M	1.89%	13
2017 Q2	$53.6M	Buy	+1,102,781	New	+$49.9M	1.44%	27

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

PFM Health Sciences's ABT Position: Q2 2026 in Review

PFM Health Sciences reduced its Abbott (ABT) stake by 41% in Q2 2026, selling an estimated $5.31M and leaving 82,230 shares worth $7.46M. The position accounts for 0.64% of the portfolio, ranked #54.

PFM Health Sciences first reported a position in ABT in Q2 2017 and has held it in 10 quarters since. The position peaked at $105M in Q1 2018. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

PFM Health Sciences held 82,230 shares of Abbott worth $7.46M as of Q2 2026.
PFM Health Sciences sold 58,202 Abbott shares in Q2 2026, an estimated $5.31M.
Abbott made up 0.64% of PFM Health Sciences's portfolio in Q2 2026, its #54 holding.
PFM Health Sciences first reported a position in Abbott in Q2 2017 and has held it in 10 quarters since.
PFM Health Sciences's Abbott position peaked at $105M in Q1 2018.
2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.